Log In
BCIQ
Print this Print this
 

scAAV9 CLN3 (ABO-201)

  Manage Alerts
Collapse Summary General Information
Company Abeona Therapeutics Inc.
DescriptionAdeno-associated viral serotype 9 (AAV9) vector that delivers the ceroid-lipofuscinosis neuronal 3 (CLN3) gene
Molecular Target Ceroid-lipofuscinosis neuronal 3 (CLN3)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat juvenile Batten disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/08/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today